GET https://kbin.spritesserver.nl/index.php/u/@badbytes@lemmy.world/hot/2023-11-10::2023-11-10

Response
200 OK
IP
216.73.216.122
Profiled on
Token
cdb514

Security

Token

There is no security token.

Firewall

main Name
Security enabled
Stateless

Configuration

Key Value
provider security.user.provider.concrete.app_user_provider
context main
entry_point App\Security\KbinAuthenticator
user_checker App\Security\UserChecker
access_denied_handler (none)
access_denied_url (none)
authenticators 
[
  "two_factor"
  "remember_me"
  "App\Security\KbinAuthenticator"
  "App\Security\FacebookAuthenticator"
  "App\Security\GoogleAuthenticator"
  "App\Security\GithubAuthenticator"
  "App\Security\KeycloakAuthenticator"
]

Listeners

Listener Duration Response 
Symfony\Component\Security\Http\Firewall\ChannelListener {#723
  -map: Symfony\Component\Security\Http\AccessMap {#722 …}
  -logger: Monolog\Logger {#783 …}
  -httpPort: 80
  -httpsPort: 443
}
 0.00 ms (none) 
Symfony\Component\Security\Http\Firewall\ContextListener {#706
  -tokenStorage: Symfony\Component\Security\Core\Authentication\Token\Storage\TokenStorage {#1017 …}
  -sessionKey: "_security_main"
  -logger: Monolog\Logger {#783 …}
  -userProviders: Symfony\Component\DependencyInjection\Argument\RewindableGenerator {#705 …}
  -dispatcher: Symfony\Component\EventDispatcher\Debug\TraceableEventDispatcher {#747 …}
  -registered: false
  -trustResolver: Scheb\TwoFactorBundle\Security\Authentication\AuthenticationTrustResolver {#780 …}
  -sessionTrackerEnabler: Symfony\Component\Security\Core\Authentication\Token\Storage\UsageTrackingTokenStorage::enableUsageTracking(): void {#703 …}
}
 0.69 ms (none) 
Symfony\Component\Security\Http\Firewall\AuthenticatorManagerListener {#584
  -authenticatorManager: Symfony\Component\Security\Http\Authentication\AuthenticatorManager {#595 …}
}
 0.00 ms (none) 
Scheb\TwoFactorBundle\Security\Http\Firewall\TwoFactorAccessListener {#582
  -twoFactorFirewallConfig: Scheb\TwoFactorBundle\Security\TwoFactor\TwoFactorFirewallConfig {#842 …}
  -tokenStorage: Symfony\Component\Security\Core\Authentication\Token\Storage\UsageTrackingTokenStorage {#1018 …}
  -twoFactorAccessDecider: Scheb\TwoFactorBundle\Security\Authorization\TwoFactorAccessDecider {#581 …}
}
 0.04 ms (none) 
Symfony\Component\Security\Http\Firewall\AccessListener {#579
  -tokenStorage: Symfony\Component\Security\Core\Authentication\Token\Storage\UsageTrackingTokenStorage {#1018 …}
  -accessDecisionManager: Symfony\Component\Security\Core\Authorization\TraceableAccessDecisionManager {#937 …}
  -map: Symfony\Component\Security\Http\AccessMap {#722 …}
}
 0.00 ms (none) 
Symfony\Component\Security\Http\Firewall\LogoutListener {#786
  -tokenStorage: Symfony\Component\Security\Core\Authentication\Token\Storage\UsageTrackingTokenStorage {#1018 …}
  -options: [
    "csrf_parameter" => "_csrf_token"
    "csrf_token_id" => "logout"
    "logout_path" => "app_logout"
  ]
  -httpUtils: Symfony\Component\Security\Http\HttpUtils {#841 …}
  -csrfTokenManager: Symfony\Component\Security\Csrf\CsrfTokenManager {#1015 …}
  -eventDispatcher: Symfony\Component\EventDispatcher\Debug\TraceableEventDispatcher {#747 …}
}
 0.00 ms (none)

Authenticators

No authenticators have been recorded. Check previous profiles on your authentication endpoint.

Access Decision

affirmative Strategy
# Voter class
1 
"Symfony\Component\Security\Core\Authorization\Voter\AuthenticatedVoter"
2 
"Scheb\TwoFactorBundle\Security\Authorization\Voter\TwoFactorInProgressVoter"
3 
"Symfony\Component\Security\Core\Authorization\Voter\RoleHierarchyVoter"
4 
"Symfony\Component\Security\Core\Authorization\Voter\ExpressionVoter"
5 
"App\Security\Voter\EntryCommentVoter"
6 
"App\Security\Voter\EntryVoter"
7 
"App\Security\Voter\MagazineVoter"
8 
"App\Security\Voter\MessageThreadVoter"
9 
"App\Security\Voter\MessageVoter"
10 
"App\Security\Voter\NotificationVoter"
11 
"App\Security\Voter\OAuth2UserConsentVoter"
12 
"App\Security\Voter\PostCommentVoter"
13 
"App\Security\Voter\PostVoter"
14 
"App\Security\Voter\UserVoter"

Access decision log

# Result Attributes Object
1 DENIED ROLE_USER 
null
 
"Scheb\TwoFactorBundle\Security\Authorization\Voter\TwoFactorInProgressVoter"
 ACCESS ABSTAIN 
"Symfony\Component\Security\Core\Authorization\Voter\RoleHierarchyVoter"
 ACCESS DENIED 
"App\Security\Voter\EntryCommentVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\EntryVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\MagazineVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\MessageThreadVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\MessageVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\NotificationVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\OAuth2UserConsentVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\PostCommentVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\PostVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\UserVoter"
 ACCESS ABSTAIN
Show voter details
2 DENIED moderate 
Proxies\__CG__\App\Entity\Entry {#1582
  +user: Proxies\__CG__\App\Entity\User {#2453 …}
  +magazine: Proxies\__CG__\App\Entity\Magazine {#1574 …}
  +image: Proxies\__CG__\App\Entity\Image {#1720 …}
  +domain: Proxies\__CG__\App\Entity\Domain {#1617 …}
  +slug: "New-toothpaste-may-reduce-allergic-reactions-to-peanuts-in-adults"
  +title: "New toothpaste may reduce allergic reactions to peanuts in adults"
  +url: "https://www.nbcnews.com/health/health-news/new-toothpaste-may-reduce-allergic-reactions-peanuts-adults-rcna123853"
  +body: """
    Scientists have developed a new toothpaste that shows potential to prevent severe allergic reactions in adults with peanut allergies.\n
    \n
    An early-stage clinical trial tested whether 32 adults with peanut allergies could safely brush their teeth with the toothpaste, which contains trace amounts of peanut protein. The hope is that introducing small amounts of peanuts to the body over time will help the immune system get used to the allergen and reduce severe reactions.\n
    \n
    Adults in the trial used the toothpaste once daily for about 11 months. At the end of the study, none of the participants experienced severe reactions or anaphylaxis — an allergic response often characterized by difficulty breathing, swelling in the throat, pale skin, blue lips, fainting or dizziness.
    """
  +type: "link"
  +lang: "en"
  +isOc: false
  +hasEmbed: false
  +commentCount: 7
  +favouriteCount: 105
  +score: 0
  +isAdult: false
  +sticky: false
  +lastActive: DateTime @1699659285 {#1567
    date: 2023-11-11 00:34:45.0 +01:00
  }
  +ip: null
  +adaAmount: 0
  +tags: null
  +mentions: null
  +comments: Doctrine\ORM\PersistentCollection {#1731 …}
  +votes: Doctrine\ORM\PersistentCollection {#1723 …}
  +reports: Doctrine\ORM\PersistentCollection {#1726 …}
  +favourites: Doctrine\ORM\PersistentCollection {#2370 …}
  +notifications: Doctrine\ORM\PersistentCollection {#1619 …}
  +badges: Doctrine\ORM\PersistentCollection {#2469 …}
  +children: [
    App\Entity\EntryComment {#1709
      +user: App\Entity\User {#264 …}
      +entry: Proxies\__CG__\App\Entity\Entry {#1582 …2}
      +magazine: Proxies\__CG__\App\Entity\Magazine {#1574 …}
      +image: null
      +parent: null
      +root: null
      +body: "Half of tube should be jelly. Patent pending."
      +lang: "en"
      +isAdult: false
      +favouriteCount: 15
      +score: 0
      +lastActive: DateTime @1699643224 {#1435
        date: 2023-11-10 20:07:04.0 +01:00
      }
      +ip: null
      +tags: null
      +mentions: [
        "@MicroWave@lemmy.world"
      ]
      +children: Doctrine\ORM\PersistentCollection {#1572 …}
      +nested: Doctrine\ORM\PersistentCollection {#1581 …}
      +votes: Doctrine\ORM\PersistentCollection {#1579 …}
      +reports: Doctrine\ORM\PersistentCollection {#1577 …}
      +favourites: Doctrine\ORM\PersistentCollection {#1573 …}
      +notifications: Doctrine\ORM\PersistentCollection {#1650 …}
      -id: 108715
      -bodyTs: "'half':1 'jelli':6 'patent':7 'pend':8 'tube':3"
      +ranking: 0
      +commentCount: 0
      +upVotes: 0
      +downVotes: 0
      +visibility: "visible             "
      +apId: "https://lemmy.world/comment/5215472"
      +editedAt: null
      +createdAt: DateTimeImmutable @1699643224 {#1438
        date: 2023-11-10 20:07:04.0 +01:00
      }
      +"title": 108715
    }
  ]
  -id: 11803
  -titleTs: "'adult':10 'allerg':5 'may':3 'new':1 'peanut':8 'reaction':6 'reduc':4 'toothpast':2"
  -bodyTs: "'11':87 '32':28 'adult':16,29,76 'allerg':13,105 'allergen':71 'allergi':19,32 'amount':44,54 'anaphylaxi':103 'blue':118 'bodi':59 'breath':111 'brush':35 'character':108 'clinic':24 'contain':42 'could':33 'daili':84 'develop':3 'difficulti':110 'dizzi':122 'earli':22 'early-stag':21 'end':91 'experienc':99 'faint':120 'get':67 'help':63 'hope':49 'immun':65 'introduc':52 'lip':119 'month':88 'new':5 'none':95 'often':107 'pale':116 'particip':98 'peanut':18,31,46,56 'potenti':9 'prevent':11 'protein':47 'reaction':14,75,101 'reduc':73 'respons':106 'safe':34 'scientist':1 'sever':12,74,100 'show':8 'skin':117 'small':53 'stage':23 'studi':94 'swell':112 'system':66 'teeth':37 'test':26 'throat':115 'time':61 'toothpast':6,40,82 'trace':43 'trial':25,79 'use':68,80 'whether':27"
  +cross: false
  +upVotes: 0
  +downVotes: 0
  +ranking: 1699721921
  +visibility: "visible             "
  +apId: "https://lemmy.world/post/8070249"
  +editedAt: null
  +createdAt: DateTimeImmutable @1699635521 {#1696
    date: 2023-11-10 17:58:41.0 +01:00
  }
  +__isInitialized__: true
   …2
}
 
"Scheb\TwoFactorBundle\Security\Authorization\Voter\TwoFactorInProgressVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\EntryCommentVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\EntryVoter"
 ACCESS DENIED 
"App\Security\Voter\MagazineVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\MessageThreadVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\MessageVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\NotificationVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\OAuth2UserConsentVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\PostCommentVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\PostVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\UserVoter"
 ACCESS ABSTAIN
Show voter details
3 DENIED edit 
Proxies\__CG__\App\Entity\Entry {#1582
  +user: Proxies\__CG__\App\Entity\User {#2453 …}
  +magazine: Proxies\__CG__\App\Entity\Magazine {#1574 …}
  +image: Proxies\__CG__\App\Entity\Image {#1720 …}
  +domain: Proxies\__CG__\App\Entity\Domain {#1617 …}
  +slug: "New-toothpaste-may-reduce-allergic-reactions-to-peanuts-in-adults"
  +title: "New toothpaste may reduce allergic reactions to peanuts in adults"
  +url: "https://www.nbcnews.com/health/health-news/new-toothpaste-may-reduce-allergic-reactions-peanuts-adults-rcna123853"
  +body: """
    Scientists have developed a new toothpaste that shows potential to prevent severe allergic reactions in adults with peanut allergies.\n
    \n
    An early-stage clinical trial tested whether 32 adults with peanut allergies could safely brush their teeth with the toothpaste, which contains trace amounts of peanut protein. The hope is that introducing small amounts of peanuts to the body over time will help the immune system get used to the allergen and reduce severe reactions.\n
    \n
    Adults in the trial used the toothpaste once daily for about 11 months. At the end of the study, none of the participants experienced severe reactions or anaphylaxis — an allergic response often characterized by difficulty breathing, swelling in the throat, pale skin, blue lips, fainting or dizziness.
    """
  +type: "link"
  +lang: "en"
  +isOc: false
  +hasEmbed: false
  +commentCount: 7
  +favouriteCount: 105
  +score: 0
  +isAdult: false
  +sticky: false
  +lastActive: DateTime @1699659285 {#1567
    date: 2023-11-11 00:34:45.0 +01:00
  }
  +ip: null
  +adaAmount: 0
  +tags: null
  +mentions: null
  +comments: Doctrine\ORM\PersistentCollection {#1731 …}
  +votes: Doctrine\ORM\PersistentCollection {#1723 …}
  +reports: Doctrine\ORM\PersistentCollection {#1726 …}
  +favourites: Doctrine\ORM\PersistentCollection {#2370 …}
  +notifications: Doctrine\ORM\PersistentCollection {#1619 …}
  +badges: Doctrine\ORM\PersistentCollection {#2469 …}
  +children: [
    App\Entity\EntryComment {#1709
      +user: App\Entity\User {#264 …}
      +entry: Proxies\__CG__\App\Entity\Entry {#1582 …2}
      +magazine: Proxies\__CG__\App\Entity\Magazine {#1574 …}
      +image: null
      +parent: null
      +root: null
      +body: "Half of tube should be jelly. Patent pending."
      +lang: "en"
      +isAdult: false
      +favouriteCount: 15
      +score: 0
      +lastActive: DateTime @1699643224 {#1435
        date: 2023-11-10 20:07:04.0 +01:00
      }
      +ip: null
      +tags: null
      +mentions: [
        "@MicroWave@lemmy.world"
      ]
      +children: Doctrine\ORM\PersistentCollection {#1572 …}
      +nested: Doctrine\ORM\PersistentCollection {#1581 …}
      +votes: Doctrine\ORM\PersistentCollection {#1579 …}
      +reports: Doctrine\ORM\PersistentCollection {#1577 …}
      +favourites: Doctrine\ORM\PersistentCollection {#1573 …}
      +notifications: Doctrine\ORM\PersistentCollection {#1650 …}
      -id: 108715
      -bodyTs: "'half':1 'jelli':6 'patent':7 'pend':8 'tube':3"
      +ranking: 0
      +commentCount: 0
      +upVotes: 0
      +downVotes: 0
      +visibility: "visible             "
      +apId: "https://lemmy.world/comment/5215472"
      +editedAt: null
      +createdAt: DateTimeImmutable @1699643224 {#1438
        date: 2023-11-10 20:07:04.0 +01:00
      }
      +"title": 108715
    }
  ]
  -id: 11803
  -titleTs: "'adult':10 'allerg':5 'may':3 'new':1 'peanut':8 'reaction':6 'reduc':4 'toothpast':2"
  -bodyTs: "'11':87 '32':28 'adult':16,29,76 'allerg':13,105 'allergen':71 'allergi':19,32 'amount':44,54 'anaphylaxi':103 'blue':118 'bodi':59 'breath':111 'brush':35 'character':108 'clinic':24 'contain':42 'could':33 'daili':84 'develop':3 'difficulti':110 'dizzi':122 'earli':22 'early-stag':21 'end':91 'experienc':99 'faint':120 'get':67 'help':63 'hope':49 'immun':65 'introduc':52 'lip':119 'month':88 'new':5 'none':95 'often':107 'pale':116 'particip':98 'peanut':18,31,46,56 'potenti':9 'prevent':11 'protein':47 'reaction':14,75,101 'reduc':73 'respons':106 'safe':34 'scientist':1 'sever':12,74,100 'show':8 'skin':117 'small':53 'stage':23 'studi':94 'swell':112 'system':66 'teeth':37 'test':26 'throat':115 'time':61 'toothpast':6,40,82 'trace':43 'trial':25,79 'use':68,80 'whether':27"
  +cross: false
  +upVotes: 0
  +downVotes: 0
  +ranking: 1699721921
  +visibility: "visible             "
  +apId: "https://lemmy.world/post/8070249"
  +editedAt: null
  +createdAt: DateTimeImmutable @1699635521 {#1696
    date: 2023-11-10 17:58:41.0 +01:00
  }
  +__isInitialized__: true
   …2
}
 
"Scheb\TwoFactorBundle\Security\Authorization\Voter\TwoFactorInProgressVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\EntryCommentVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\EntryVoter"
 ACCESS DENIED 
"App\Security\Voter\MagazineVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\MessageThreadVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\MessageVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\NotificationVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\OAuth2UserConsentVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\PostCommentVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\PostVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\UserVoter"
 ACCESS ABSTAIN
Show voter details
4 DENIED moderate 
Proxies\__CG__\App\Entity\Entry {#1582
  +user: Proxies\__CG__\App\Entity\User {#2453 …}
  +magazine: Proxies\__CG__\App\Entity\Magazine {#1574 …}
  +image: Proxies\__CG__\App\Entity\Image {#1720 …}
  +domain: Proxies\__CG__\App\Entity\Domain {#1617 …}
  +slug: "New-toothpaste-may-reduce-allergic-reactions-to-peanuts-in-adults"
  +title: "New toothpaste may reduce allergic reactions to peanuts in adults"
  +url: "https://www.nbcnews.com/health/health-news/new-toothpaste-may-reduce-allergic-reactions-peanuts-adults-rcna123853"
  +body: """
    Scientists have developed a new toothpaste that shows potential to prevent severe allergic reactions in adults with peanut allergies.\n
    \n
    An early-stage clinical trial tested whether 32 adults with peanut allergies could safely brush their teeth with the toothpaste, which contains trace amounts of peanut protein. The hope is that introducing small amounts of peanuts to the body over time will help the immune system get used to the allergen and reduce severe reactions.\n
    \n
    Adults in the trial used the toothpaste once daily for about 11 months. At the end of the study, none of the participants experienced severe reactions or anaphylaxis — an allergic response often characterized by difficulty breathing, swelling in the throat, pale skin, blue lips, fainting or dizziness.
    """
  +type: "link"
  +lang: "en"
  +isOc: false
  +hasEmbed: false
  +commentCount: 7
  +favouriteCount: 105
  +score: 0
  +isAdult: false
  +sticky: false
  +lastActive: DateTime @1699659285 {#1567
    date: 2023-11-11 00:34:45.0 +01:00
  }
  +ip: null
  +adaAmount: 0
  +tags: null
  +mentions: null
  +comments: Doctrine\ORM\PersistentCollection {#1731 …}
  +votes: Doctrine\ORM\PersistentCollection {#1723 …}
  +reports: Doctrine\ORM\PersistentCollection {#1726 …}
  +favourites: Doctrine\ORM\PersistentCollection {#2370 …}
  +notifications: Doctrine\ORM\PersistentCollection {#1619 …}
  +badges: Doctrine\ORM\PersistentCollection {#2469 …}
  +children: [
    App\Entity\EntryComment {#1709
      +user: App\Entity\User {#264 …}
      +entry: Proxies\__CG__\App\Entity\Entry {#1582 …2}
      +magazine: Proxies\__CG__\App\Entity\Magazine {#1574 …}
      +image: null
      +parent: null
      +root: null
      +body: "Half of tube should be jelly. Patent pending."
      +lang: "en"
      +isAdult: false
      +favouriteCount: 15
      +score: 0
      +lastActive: DateTime @1699643224 {#1435
        date: 2023-11-10 20:07:04.0 +01:00
      }
      +ip: null
      +tags: null
      +mentions: [
        "@MicroWave@lemmy.world"
      ]
      +children: Doctrine\ORM\PersistentCollection {#1572 …}
      +nested: Doctrine\ORM\PersistentCollection {#1581 …}
      +votes: Doctrine\ORM\PersistentCollection {#1579 …}
      +reports: Doctrine\ORM\PersistentCollection {#1577 …}
      +favourites: Doctrine\ORM\PersistentCollection {#1573 …}
      +notifications: Doctrine\ORM\PersistentCollection {#1650 …}
      -id: 108715
      -bodyTs: "'half':1 'jelli':6 'patent':7 'pend':8 'tube':3"
      +ranking: 0
      +commentCount: 0
      +upVotes: 0
      +downVotes: 0
      +visibility: "visible             "
      +apId: "https://lemmy.world/comment/5215472"
      +editedAt: null
      +createdAt: DateTimeImmutable @1699643224 {#1438
        date: 2023-11-10 20:07:04.0 +01:00
      }
      +"title": 108715
    }
  ]
  -id: 11803
  -titleTs: "'adult':10 'allerg':5 'may':3 'new':1 'peanut':8 'reaction':6 'reduc':4 'toothpast':2"
  -bodyTs: "'11':87 '32':28 'adult':16,29,76 'allerg':13,105 'allergen':71 'allergi':19,32 'amount':44,54 'anaphylaxi':103 'blue':118 'bodi':59 'breath':111 'brush':35 'character':108 'clinic':24 'contain':42 'could':33 'daili':84 'develop':3 'difficulti':110 'dizzi':122 'earli':22 'early-stag':21 'end':91 'experienc':99 'faint':120 'get':67 'help':63 'hope':49 'immun':65 'introduc':52 'lip':119 'month':88 'new':5 'none':95 'often':107 'pale':116 'particip':98 'peanut':18,31,46,56 'potenti':9 'prevent':11 'protein':47 'reaction':14,75,101 'reduc':73 'respons':106 'safe':34 'scientist':1 'sever':12,74,100 'show':8 'skin':117 'small':53 'stage':23 'studi':94 'swell':112 'system':66 'teeth':37 'test':26 'throat':115 'time':61 'toothpast':6,40,82 'trace':43 'trial':25,79 'use':68,80 'whether':27"
  +cross: false
  +upVotes: 0
  +downVotes: 0
  +ranking: 1699721921
  +visibility: "visible             "
  +apId: "https://lemmy.world/post/8070249"
  +editedAt: null
  +createdAt: DateTimeImmutable @1699635521 {#1696
    date: 2023-11-10 17:58:41.0 +01:00
  }
  +__isInitialized__: true
   …2
}
 
"Scheb\TwoFactorBundle\Security\Authorization\Voter\TwoFactorInProgressVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\EntryCommentVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\EntryVoter"
 ACCESS DENIED 
"App\Security\Voter\MagazineVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\MessageThreadVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\MessageVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\NotificationVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\OAuth2UserConsentVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\PostCommentVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\PostVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\UserVoter"
 ACCESS ABSTAIN
Show voter details
5 DENIED ROLE_USER 
null
 
"Scheb\TwoFactorBundle\Security\Authorization\Voter\TwoFactorInProgressVoter"
 ACCESS ABSTAIN 
"Symfony\Component\Security\Core\Authorization\Voter\RoleHierarchyVoter"
 ACCESS DENIED 
"App\Security\Voter\EntryCommentVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\EntryVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\MagazineVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\MessageThreadVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\MessageVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\NotificationVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\OAuth2UserConsentVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\PostCommentVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\PostVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\UserVoter"
 ACCESS ABSTAIN
Show voter details
6 DENIED moderate 
App\Entity\EntryComment {#1709
  +user: App\Entity\User {#264 …}
  +entry: Proxies\__CG__\App\Entity\Entry {#1582
    +user: Proxies\__CG__\App\Entity\User {#2453 …}
    +magazine: Proxies\__CG__\App\Entity\Magazine {#1574 …}
    +image: Proxies\__CG__\App\Entity\Image {#1720 …}
    +domain: Proxies\__CG__\App\Entity\Domain {#1617 …}
    +slug: "New-toothpaste-may-reduce-allergic-reactions-to-peanuts-in-adults"
    +title: "New toothpaste may reduce allergic reactions to peanuts in adults"
    +url: "https://www.nbcnews.com/health/health-news/new-toothpaste-may-reduce-allergic-reactions-peanuts-adults-rcna123853"
    +body: """
      Scientists have developed a new toothpaste that shows potential to prevent severe allergic reactions in adults with peanut allergies.\n
      \n
      An early-stage clinical trial tested whether 32 adults with peanut allergies could safely brush their teeth with the toothpaste, which contains trace amounts of peanut protein. The hope is that introducing small amounts of peanuts to the body over time will help the immune system get used to the allergen and reduce severe reactions.\n
      \n
      Adults in the trial used the toothpaste once daily for about 11 months. At the end of the study, none of the participants experienced severe reactions or anaphylaxis — an allergic response often characterized by difficulty breathing, swelling in the throat, pale skin, blue lips, fainting or dizziness.
      """
    +type: "link"
    +lang: "en"
    +isOc: false
    +hasEmbed: false
    +commentCount: 7
    +favouriteCount: 105
    +score: 0
    +isAdult: false
    +sticky: false
    +lastActive: DateTime @1699659285 {#1567
      date: 2023-11-11 00:34:45.0 +01:00
    }
    +ip: null
    +adaAmount: 0
    +tags: null
    +mentions: null
    +comments: Doctrine\ORM\PersistentCollection {#1731 …}
    +votes: Doctrine\ORM\PersistentCollection {#1723 …}
    +reports: Doctrine\ORM\PersistentCollection {#1726 …}
    +favourites: Doctrine\ORM\PersistentCollection {#2370 …}
    +notifications: Doctrine\ORM\PersistentCollection {#1619 …}
    +badges: Doctrine\ORM\PersistentCollection {#2469 …}
    +children: [
      App\Entity\EntryComment {#1709}
    ]
    -id: 11803
    -titleTs: "'adult':10 'allerg':5 'may':3 'new':1 'peanut':8 'reaction':6 'reduc':4 'toothpast':2"
    -bodyTs: "'11':87 '32':28 'adult':16,29,76 'allerg':13,105 'allergen':71 'allergi':19,32 'amount':44,54 'anaphylaxi':103 'blue':118 'bodi':59 'breath':111 'brush':35 'character':108 'clinic':24 'contain':42 'could':33 'daili':84 'develop':3 'difficulti':110 'dizzi':122 'earli':22 'early-stag':21 'end':91 'experienc':99 'faint':120 'get':67 'help':63 'hope':49 'immun':65 'introduc':52 'lip':119 'month':88 'new':5 'none':95 'often':107 'pale':116 'particip':98 'peanut':18,31,46,56 'potenti':9 'prevent':11 'protein':47 'reaction':14,75,101 'reduc':73 'respons':106 'safe':34 'scientist':1 'sever':12,74,100 'show':8 'skin':117 'small':53 'stage':23 'studi':94 'swell':112 'system':66 'teeth':37 'test':26 'throat':115 'time':61 'toothpast':6,40,82 'trace':43 'trial':25,79 'use':68,80 'whether':27"
    +cross: false
    +upVotes: 0
    +downVotes: 0
    +ranking: 1699721921
    +visibility: "visible             "
    +apId: "https://lemmy.world/post/8070249"
    +editedAt: null
    +createdAt: DateTimeImmutable @1699635521 {#1696
      date: 2023-11-10 17:58:41.0 +01:00
    }
    +__isInitialized__: true
     …2
  }
  +magazine: Proxies\__CG__\App\Entity\Magazine {#1574 …}
  +image: null
  +parent: null
  +root: null
  +body: "Half of tube should be jelly. Patent pending."
  +lang: "en"
  +isAdult: false
  +favouriteCount: 15
  +score: 0
  +lastActive: DateTime @1699643224 {#1435
    date: 2023-11-10 20:07:04.0 +01:00
  }
  +ip: null
  +tags: null
  +mentions: [
    "@MicroWave@lemmy.world"
  ]
  +children: Doctrine\ORM\PersistentCollection {#1572 …}
  +nested: Doctrine\ORM\PersistentCollection {#1581 …}
  +votes: Doctrine\ORM\PersistentCollection {#1579 …}
  +reports: Doctrine\ORM\PersistentCollection {#1577 …}
  +favourites: Doctrine\ORM\PersistentCollection {#1573 …}
  +notifications: Doctrine\ORM\PersistentCollection {#1650 …}
  -id: 108715
  -bodyTs: "'half':1 'jelli':6 'patent':7 'pend':8 'tube':3"
  +ranking: 0
  +commentCount: 0
  +upVotes: 0
  +downVotes: 0
  +visibility: "visible             "
  +apId: "https://lemmy.world/comment/5215472"
  +editedAt: null
  +createdAt: DateTimeImmutable @1699643224 {#1438
    date: 2023-11-10 20:07:04.0 +01:00
  }
  +"title": 108715
}
 
"Scheb\TwoFactorBundle\Security\Authorization\Voter\TwoFactorInProgressVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\EntryCommentVoter"
 ACCESS DENIED 
"App\Security\Voter\EntryVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\MagazineVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\MessageThreadVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\MessageVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\NotificationVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\OAuth2UserConsentVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\PostCommentVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\PostVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\UserVoter"
 ACCESS ABSTAIN
Show voter details
7 DENIED edit 
App\Entity\EntryComment {#1709
  +user: App\Entity\User {#264 …}
  +entry: Proxies\__CG__\App\Entity\Entry {#1582
    +user: Proxies\__CG__\App\Entity\User {#2453 …}
    +magazine: Proxies\__CG__\App\Entity\Magazine {#1574 …}
    +image: Proxies\__CG__\App\Entity\Image {#1720 …}
    +domain: Proxies\__CG__\App\Entity\Domain {#1617 …}
    +slug: "New-toothpaste-may-reduce-allergic-reactions-to-peanuts-in-adults"
    +title: "New toothpaste may reduce allergic reactions to peanuts in adults"
    +url: "https://www.nbcnews.com/health/health-news/new-toothpaste-may-reduce-allergic-reactions-peanuts-adults-rcna123853"
    +body: """
      Scientists have developed a new toothpaste that shows potential to prevent severe allergic reactions in adults with peanut allergies.\n
      \n
      An early-stage clinical trial tested whether 32 adults with peanut allergies could safely brush their teeth with the toothpaste, which contains trace amounts of peanut protein. The hope is that introducing small amounts of peanuts to the body over time will help the immune system get used to the allergen and reduce severe reactions.\n
      \n
      Adults in the trial used the toothpaste once daily for about 11 months. At the end of the study, none of the participants experienced severe reactions or anaphylaxis — an allergic response often characterized by difficulty breathing, swelling in the throat, pale skin, blue lips, fainting or dizziness.
      """
    +type: "link"
    +lang: "en"
    +isOc: false
    +hasEmbed: false
    +commentCount: 7
    +favouriteCount: 105
    +score: 0
    +isAdult: false
    +sticky: false
    +lastActive: DateTime @1699659285 {#1567
      date: 2023-11-11 00:34:45.0 +01:00
    }
    +ip: null
    +adaAmount: 0
    +tags: null
    +mentions: null
    +comments: Doctrine\ORM\PersistentCollection {#1731 …}
    +votes: Doctrine\ORM\PersistentCollection {#1723 …}
    +reports: Doctrine\ORM\PersistentCollection {#1726 …}
    +favourites: Doctrine\ORM\PersistentCollection {#2370 …}
    +notifications: Doctrine\ORM\PersistentCollection {#1619 …}
    +badges: Doctrine\ORM\PersistentCollection {#2469 …}
    +children: [
      App\Entity\EntryComment {#1709}
    ]
    -id: 11803
    -titleTs: "'adult':10 'allerg':5 'may':3 'new':1 'peanut':8 'reaction':6 'reduc':4 'toothpast':2"
    -bodyTs: "'11':87 '32':28 'adult':16,29,76 'allerg':13,105 'allergen':71 'allergi':19,32 'amount':44,54 'anaphylaxi':103 'blue':118 'bodi':59 'breath':111 'brush':35 'character':108 'clinic':24 'contain':42 'could':33 'daili':84 'develop':3 'difficulti':110 'dizzi':122 'earli':22 'early-stag':21 'end':91 'experienc':99 'faint':120 'get':67 'help':63 'hope':49 'immun':65 'introduc':52 'lip':119 'month':88 'new':5 'none':95 'often':107 'pale':116 'particip':98 'peanut':18,31,46,56 'potenti':9 'prevent':11 'protein':47 'reaction':14,75,101 'reduc':73 'respons':106 'safe':34 'scientist':1 'sever':12,74,100 'show':8 'skin':117 'small':53 'stage':23 'studi':94 'swell':112 'system':66 'teeth':37 'test':26 'throat':115 'time':61 'toothpast':6,40,82 'trace':43 'trial':25,79 'use':68,80 'whether':27"
    +cross: false
    +upVotes: 0
    +downVotes: 0
    +ranking: 1699721921
    +visibility: "visible             "
    +apId: "https://lemmy.world/post/8070249"
    +editedAt: null
    +createdAt: DateTimeImmutable @1699635521 {#1696
      date: 2023-11-10 17:58:41.0 +01:00
    }
    +__isInitialized__: true
     …2
  }
  +magazine: Proxies\__CG__\App\Entity\Magazine {#1574 …}
  +image: null
  +parent: null
  +root: null
  +body: "Half of tube should be jelly. Patent pending."
  +lang: "en"
  +isAdult: false
  +favouriteCount: 15
  +score: 0
  +lastActive: DateTime @1699643224 {#1435
    date: 2023-11-10 20:07:04.0 +01:00
  }
  +ip: null
  +tags: null
  +mentions: [
    "@MicroWave@lemmy.world"
  ]
  +children: Doctrine\ORM\PersistentCollection {#1572 …}
  +nested: Doctrine\ORM\PersistentCollection {#1581 …}
  +votes: Doctrine\ORM\PersistentCollection {#1579 …}
  +reports: Doctrine\ORM\PersistentCollection {#1577 …}
  +favourites: Doctrine\ORM\PersistentCollection {#1573 …}
  +notifications: Doctrine\ORM\PersistentCollection {#1650 …}
  -id: 108715
  -bodyTs: "'half':1 'jelli':6 'patent':7 'pend':8 'tube':3"
  +ranking: 0
  +commentCount: 0
  +upVotes: 0
  +downVotes: 0
  +visibility: "visible             "
  +apId: "https://lemmy.world/comment/5215472"
  +editedAt: null
  +createdAt: DateTimeImmutable @1699643224 {#1438
    date: 2023-11-10 20:07:04.0 +01:00
  }
  +"title": 108715
}
 
"Scheb\TwoFactorBundle\Security\Authorization\Voter\TwoFactorInProgressVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\EntryCommentVoter"
 ACCESS DENIED 
"App\Security\Voter\EntryVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\MagazineVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\MessageThreadVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\MessageVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\NotificationVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\OAuth2UserConsentVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\PostCommentVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\PostVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\UserVoter"
 ACCESS ABSTAIN
Show voter details
8 DENIED moderate 
App\Entity\EntryComment {#1709
  +user: App\Entity\User {#264 …}
  +entry: Proxies\__CG__\App\Entity\Entry {#1582
    +user: Proxies\__CG__\App\Entity\User {#2453 …}
    +magazine: Proxies\__CG__\App\Entity\Magazine {#1574 …}
    +image: Proxies\__CG__\App\Entity\Image {#1720 …}
    +domain: Proxies\__CG__\App\Entity\Domain {#1617 …}
    +slug: "New-toothpaste-may-reduce-allergic-reactions-to-peanuts-in-adults"
    +title: "New toothpaste may reduce allergic reactions to peanuts in adults"
    +url: "https://www.nbcnews.com/health/health-news/new-toothpaste-may-reduce-allergic-reactions-peanuts-adults-rcna123853"
    +body: """
      Scientists have developed a new toothpaste that shows potential to prevent severe allergic reactions in adults with peanut allergies.\n
      \n
      An early-stage clinical trial tested whether 32 adults with peanut allergies could safely brush their teeth with the toothpaste, which contains trace amounts of peanut protein. The hope is that introducing small amounts of peanuts to the body over time will help the immune system get used to the allergen and reduce severe reactions.\n
      \n
      Adults in the trial used the toothpaste once daily for about 11 months. At the end of the study, none of the participants experienced severe reactions or anaphylaxis — an allergic response often characterized by difficulty breathing, swelling in the throat, pale skin, blue lips, fainting or dizziness.
      """
    +type: "link"
    +lang: "en"
    +isOc: false
    +hasEmbed: false
    +commentCount: 7
    +favouriteCount: 105
    +score: 0
    +isAdult: false
    +sticky: false
    +lastActive: DateTime @1699659285 {#1567
      date: 2023-11-11 00:34:45.0 +01:00
    }
    +ip: null
    +adaAmount: 0
    +tags: null
    +mentions: null
    +comments: Doctrine\ORM\PersistentCollection {#1731 …}
    +votes: Doctrine\ORM\PersistentCollection {#1723 …}
    +reports: Doctrine\ORM\PersistentCollection {#1726 …}
    +favourites: Doctrine\ORM\PersistentCollection {#2370 …}
    +notifications: Doctrine\ORM\PersistentCollection {#1619 …}
    +badges: Doctrine\ORM\PersistentCollection {#2469 …}
    +children: [
      App\Entity\EntryComment {#1709}
    ]
    -id: 11803
    -titleTs: "'adult':10 'allerg':5 'may':3 'new':1 'peanut':8 'reaction':6 'reduc':4 'toothpast':2"
    -bodyTs: "'11':87 '32':28 'adult':16,29,76 'allerg':13,105 'allergen':71 'allergi':19,32 'amount':44,54 'anaphylaxi':103 'blue':118 'bodi':59 'breath':111 'brush':35 'character':108 'clinic':24 'contain':42 'could':33 'daili':84 'develop':3 'difficulti':110 'dizzi':122 'earli':22 'early-stag':21 'end':91 'experienc':99 'faint':120 'get':67 'help':63 'hope':49 'immun':65 'introduc':52 'lip':119 'month':88 'new':5 'none':95 'often':107 'pale':116 'particip':98 'peanut':18,31,46,56 'potenti':9 'prevent':11 'protein':47 'reaction':14,75,101 'reduc':73 'respons':106 'safe':34 'scientist':1 'sever':12,74,100 'show':8 'skin':117 'small':53 'stage':23 'studi':94 'swell':112 'system':66 'teeth':37 'test':26 'throat':115 'time':61 'toothpast':6,40,82 'trace':43 'trial':25,79 'use':68,80 'whether':27"
    +cross: false
    +upVotes: 0
    +downVotes: 0
    +ranking: 1699721921
    +visibility: "visible             "
    +apId: "https://lemmy.world/post/8070249"
    +editedAt: null
    +createdAt: DateTimeImmutable @1699635521 {#1696
      date: 2023-11-10 17:58:41.0 +01:00
    }
    +__isInitialized__: true
     …2
  }
  +magazine: Proxies\__CG__\App\Entity\Magazine {#1574 …}
  +image: null
  +parent: null
  +root: null
  +body: "Half of tube should be jelly. Patent pending."
  +lang: "en"
  +isAdult: false
  +favouriteCount: 15
  +score: 0
  +lastActive: DateTime @1699643224 {#1435
    date: 2023-11-10 20:07:04.0 +01:00
  }
  +ip: null
  +tags: null
  +mentions: [
    "@MicroWave@lemmy.world"
  ]
  +children: Doctrine\ORM\PersistentCollection {#1572 …}
  +nested: Doctrine\ORM\PersistentCollection {#1581 …}
  +votes: Doctrine\ORM\PersistentCollection {#1579 …}
  +reports: Doctrine\ORM\PersistentCollection {#1577 …}
  +favourites: Doctrine\ORM\PersistentCollection {#1573 …}
  +notifications: Doctrine\ORM\PersistentCollection {#1650 …}
  -id: 108715
  -bodyTs: "'half':1 'jelli':6 'patent':7 'pend':8 'tube':3"
  +ranking: 0
  +commentCount: 0
  +upVotes: 0
  +downVotes: 0
  +visibility: "visible             "
  +apId: "https://lemmy.world/comment/5215472"
  +editedAt: null
  +createdAt: DateTimeImmutable @1699643224 {#1438
    date: 2023-11-10 20:07:04.0 +01:00
  }
  +"title": 108715
}
 
"Scheb\TwoFactorBundle\Security\Authorization\Voter\TwoFactorInProgressVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\EntryCommentVoter"
 ACCESS DENIED 
"App\Security\Voter\EntryVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\MagazineVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\MessageThreadVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\MessageVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\NotificationVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\OAuth2UserConsentVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\PostCommentVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\PostVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\UserVoter"
 ACCESS ABSTAIN
Show voter details
9 DENIED ROLE_ADMIN 
null
 
"Scheb\TwoFactorBundle\Security\Authorization\Voter\TwoFactorInProgressVoter"
 ACCESS ABSTAIN 
"Symfony\Component\Security\Core\Authorization\Voter\RoleHierarchyVoter"
 ACCESS DENIED 
"App\Security\Voter\EntryCommentVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\EntryVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\MagazineVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\MessageThreadVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\MessageVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\NotificationVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\OAuth2UserConsentVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\PostCommentVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\PostVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\UserVoter"
 ACCESS ABSTAIN
Show voter details
10 DENIED ROLE_MODERATOR 
null
 
"Scheb\TwoFactorBundle\Security\Authorization\Voter\TwoFactorInProgressVoter"
 ACCESS ABSTAIN 
"Symfony\Component\Security\Core\Authorization\Voter\RoleHierarchyVoter"
 ACCESS DENIED 
"App\Security\Voter\EntryCommentVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\EntryVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\MagazineVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\MessageThreadVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\MessageVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\NotificationVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\OAuth2UserConsentVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\PostCommentVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\PostVoter"
 ACCESS ABSTAIN 
"App\Security\Voter\UserVoter"
 ACCESS ABSTAIN
Show voter details